Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Indian scientists demonstrate protective effect of NAP against stress organ injury in malaria

Jan. 5, 1998

Oral ganciclovir tested for prevention of CMV disease in transplant recipients

Jan. 5, 1998

Abelcet now approved in 18 countries

Jan. 5, 1998

Antifungal agents prepared at Pola

Jan. 5, 1998

Anti-MRSA agents prepared at Bristol-Myers Squibb

Jan. 2, 1998

New antifungals from Lilly

Jan. 2, 1998

Abbott synthesizes a novel series of cyclic antifungal agents

Jan. 2, 1998

Raxar --new once-daily fluoroquinolone-- now available in U.S.

Dec. 31, 1997

New antifungals disclosed by Schering-Plough

Dec. 31, 1997

Lilly develops compounds for the common cold; selects development candidate

Dec. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...